HLF HERBALIFE LTD.

NYSE herbalife.com


$ 9.09 $ -0.11 (-1.2 %)    

Friday, 07-Nov-2025 16:28:27 EST
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 9.09
$ 9.15
$ 8.30 x 60
$ 9.20 x 100
$ 8.50 - $ 9.20
$ 5.04 - $ 10.83
2,612,471
na
939.09M
$ 0.64
$ 2.93
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 04-30-2025 03-31-2025 10-Q
4 02-19-2025 12-31-2024 10-K
5 10-30-2024 09-30-2024 10-Q
6 07-31-2024 06-30-2024 10-Q
7 05-01-2024 03-31-2024 10-Q
8 02-14-2024 12-31-2023 10-K
9 11-01-2023 09-30-2023 10-Q
10 08-02-2023 06-30-2023 10-Q
11 05-02-2023 03-31-2023 10-Q
12 02-14-2023 12-31-2022 10-K
13 10-31-2022 09-30-2022 10-Q
14 08-02-2022 06-30-2022 10-Q
15 05-03-2022 03-31-2022 10-Q
16 02-23-2022 12-31-2021 10-K
17 11-02-2021 09-30-2021 10-Q
18 08-03-2021 06-30-2021 10-Q
19 05-04-2021 03-31-2021 10-Q
20 02-17-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 02-18-2020 12-31-2019 10-K
25 10-30-2019 09-30-2019 10-Q
26 08-01-2019 06-30-2019 10-Q
27 05-02-2019 03-31-2019 10-Q
28 02-19-2019 12-31-2018 10-K
29 10-30-2018 09-30-2018 10-Q
30 08-01-2018 06-30-2018 10-Q
31 05-03-2018 03-31-2018 10-Q
32 02-22-2018 12-31-2017 10-K
33 11-02-2017 09-30-2017 10-Q
34 08-01-2017 06-30-2017 10-Q
35 05-04-2017 03-31-2017 10-Q
36 02-23-2017 12-31-2016 10-K
37 11-01-2016 09-30-2016 10-Q
38 08-03-2016 06-30-2016 10-Q
39 05-05-2016 03-31-2016 10-Q
40 02-25-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 earnings-outlook-for-herbalife
Earnings Outlook For Herbalife
11/04/2025 20:02:56

 herbalife-invests-7m-in-new-california-lab-to-boost-quality-and-innovation

Herbalife Ltd. (NYSE:HLF), a premier health and wellness company, community, and platform, has announced the opening of its new...

 herbalife-sees-q3-sales-1247b-1296b-vs-1241b-est

Herbalife (NYSE:HLF) sees Q3 sales of $1.247 billion-$1.296 billion vs $1.241 billion analyst estimate.

 herbalife-raises-fy2025-sales-guidance-from-4868b-5118b-to-4943b-5143b-vs-4948b-est

Herbalife (NYSE:HLF) raises FY2025 sales outlook from $4.868 billion-$5.118 billion to $4.943 billion-$5.143 billion vs $4.948 ...

 herbalife-q2-adj-eps-059-beats-038-estimate-sales-1259b-miss-1267b-estimate

Herbalife (NYSE:HLF) reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of $0.38 by 56.5 ...

 herbalife-earnings-preview
Herbalife Earnings Preview
08/05/2025 18:02:22

 mizuho-maintains-neutral-on-herbalife-raises-price-target-to-9

Mizuho analyst John Baumgartner maintains Herbalife (NYSE:HLF) with a Neutral and raises the price target from $8 to $9.

 herbalife-unveils-multiburn-next-gen-multi-action-dietary-supplement-to-support-weight-loss-healthy-fat-reduction-and-energy-expenditure

New daily supplement features clinically studied botanicals to support weight loss, healthy fat reduction and energy expenditur...

 herbalifes-aloe-vera-aloin-testing-method-earns-aoac-international-certification

Certified Method Enhances Global Botanical Quality and Safety

 citigroup-maintains-buy-on-herbalife-lowers-price-target-to-11

Citigroup analyst Chasen Bender maintains Herbalife (NYSE:HLF) with a Buy and lowers the price target from $13 to $11.

 herbalife-narrows-fy2025-sales-guidance-from-484b-514b-to-487b-512b-vs-496b-est

Herbalife (NYSE:HLF) narrows FY2025 sales outlook from $4.84 billion-$5.14 billion to $4.87 billion-$5.12 billion vs $4.96 bill...

 herbalife-sees-q2-sales-1236b-1288b-vs-127b-est

Herbalife (NYSE:HLF) sees Q2 sales of $1.236 billion-$1.288 billion vs $1.27 billion analyst estimate.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION